| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/18/2011 | US20110201552 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
| 08/18/2011 | US20110201542 Myeloid Protein Activation of Anti-Inflammatory and Anti-Hypoxic Pathway |
| 08/18/2011 | US20110200697 Compositions for Prophylaxis or Treatment of Cerebrovascular Diseases, for Improving Memory Impairment, or for Protecting Neuronal Cells, Containing Ethanol Extract from Aralia Elata, Chaenomelis Fructus and Glycyrrhizae Radix |
| 08/18/2011 | US20110200692 Use of a cinnamon bark extract for treating amyloid-associated diseases |
| 08/18/2011 | US20110200690 Compositions and methods for treating depression |
| 08/18/2011 | US20110200687 Bifeprunox mesylate maintenance dose compositions and methods for using the same |
| 08/18/2011 | US20110200681 Abuse Resistant Drug Formulation |
| 08/18/2011 | US20110200677 Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer |
| 08/18/2011 | US20110200675 Drug delivery vehicles, methods of manufacture, and methods of use thereof |
| 08/18/2011 | US20110200670 Nicotine Containing Soft Gelatin Pastilles |
| 08/18/2011 | US20110200639 Botulinum toxin treatments of Depression |
| 08/18/2011 | US20110200618 Erbb4 inhibitors and uses thereof in treatment of neuropsychiatric disorders |
| 08/18/2011 | US20110200613 Use of B Cell Expansion Agents in Generating Antibodies |
| 08/18/2011 | US20110200611 Plasma kallikrein binding proteins |
| 08/18/2011 | US20110200609 Monoclonal antibodies specific for pathological amyloid aggregates common to amyloids formed from proteins of differing sequence |
| 08/18/2011 | US20110200590 Antibodies Directed Against the Myelin Basic Protein Recognising an Epitope of CD64 and Their Use as Immunosuppressants |
| 08/18/2011 | US20110200575 Metallo-lactoferrin-coenzyme compositions to improve sleep patterns |
| 08/18/2011 | US20110200564 Diagnosis and treatment of alzheimer's disease (ad) |
| 08/18/2011 | US20110200557 New 2-amidothiadiazole derivatives |
| 08/18/2011 | US20110200555 Conjugates of hydroxyalkyl starch and a protein |
| 08/18/2011 | US20110200535 Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment |
| 08/18/2011 | US20110200531 Treatment and diagnosis of central nervous system disorders |
| 08/18/2011 | CA2825428A1 Compositions and methods for treating depression |
| 08/18/2011 | CA2789663A1 5-ht4 receptor agonists for the treatment of dementia |
| 08/18/2011 | CA2789434A1 Benzisoxazoles and azabenzisoxazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 08/18/2011 | CA2789427A1 Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 08/18/2011 | CA2789082A1 Use of agomelatine for the preparation of drugs for treating obsessive compulsive disorder (ocd) |
| 08/18/2011 | CA2787727A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases |
| 08/17/2011 | EP2357474A1 Lurasidone for use in the treatment of memory or learning dysfunction by schizophrenia |
| 08/17/2011 | EP2357200A1 Human antibodies that bind human TNFalpha |
| 08/17/2011 | EP2357193A1 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 08/17/2011 | EP2357175A1 isoquinoline derivatives AND THEIR USE IN INCREASING ENDOGENEOUS ERYTHROPOIETIN |
| 08/17/2011 | EP2357174A1 Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine |
| 08/17/2011 | EP2357171A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders |
| 08/17/2011 | EP2357169A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 08/17/2011 | EP2357165A1 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders |
| 08/17/2011 | EP2357008A1 Albumin fusion proteins |
| 08/17/2011 | EP2357004A1 NRG-2 nucleic acid molecules, polypeptides and diagnostic and therapeutical methods |
| 08/17/2011 | EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation |
| 08/17/2011 | EP2356996A1 Treatment for Alzeimer's disease |
| 08/17/2011 | EP2356914A2 Composition for improving membrane composition and functioning of cells |
| 08/17/2011 | EP2356238A2 Nurr1 interacting protein (nuip) |
| 08/17/2011 | EP2356144A2 Composition for producing anti-amyloid beta peptide antibodies with d-peptides |
| 08/17/2011 | EP2356130A1 Treatment of restless leg syndrome and sleep disorders |
| 08/17/2011 | EP2356125A1 Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands |
| 08/17/2011 | EP2356124A1 Gamma secretase modulators |
| 08/17/2011 | EP2356115A1 Gamma secretase modulators |
| 08/17/2011 | EP2356108A1 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof |
| 08/17/2011 | EP2356105A1 ( pyrrolidin-2 -yl) phenyl derivatives for use in the treatment of pain |
| 08/17/2011 | EP2356101A1 Pyrimidine and triazine sulfonamide derivates as b1 bradykinin receptor (b1r) inhibitors for treating pain |
| 08/17/2011 | EP2356099A1 Tetrahydrofuranyl sulfonamides for use as ampa modulators in the treatment of cns disorders |
| 08/17/2011 | EP2355826A1 Compounds and methods of promoting oligodendrocyte precursor differentiation |
| 08/17/2011 | EP2355822A1 Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzoýb¨thiophene-2-carboxamide and pharmaceutically acceptable salts thereof |
| 08/17/2011 | EP2355818A2 Methods and compositions for treating status epilepticus and seizures causing status epilepticus |
| 08/17/2011 | EP2355814A2 Pyrones for the treatment of metabolic disorders |
| 08/17/2011 | EP2355810A2 Methods for preventing or reducing carcinogenesis or oxidative stress |
| 08/17/2011 | EP2355807A1 Inhibitors of dimethylarginine dimethylaminohydrolase |
| 08/17/2011 | EP2355660A1 Compositions and methods for treating multiple sclerosis |
| 08/17/2011 | EP2355659A1 Fused heterocyclic m1 receptor positive allosteric modulators |
| 08/17/2011 | EP2188268B1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| 08/17/2011 | EP2010531B1 Spirocyclic cyclohexane derivatives with analgesic properties |
| 08/17/2011 | EP1893608B1 Thiazolyl mglur5 antagonists and methods for their use |
| 08/17/2011 | EP1871382B1 Methods for the treatment of central nervous system injury via a tapered administration of progesterone |
| 08/17/2011 | EP1812389B1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 08/17/2011 | EP1781619B1 Sigma receptor inhibitors |
| 08/17/2011 | EP1575531B1 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 08/17/2011 | EP1572200B1 Aminoindazole derivatives and use thereof as kinase inhibitors |
| 08/17/2011 | EP1507558B1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/17/2011 | EP1456419B1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 08/17/2011 | EP1444233B1 A2b adenosine receptor antagonists |
| 08/17/2011 | EP1419768B1 Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
| 08/17/2011 | EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 08/17/2011 | EP1246808B1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 08/17/2011 | CN1715926B Use of neuregulin mutant |
| 08/17/2011 | CN102159582A Oxazolopyrimidines as edg-1 receptor agonists |
| 08/17/2011 | CN102159575A 5-oxazolidin-2-one substituted 1,3,8-triazaspiro [4.5] decan-4-one derivatives useful as orl-1 receptor modulators |
| 08/17/2011 | CN102159573A Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 08/17/2011 | CN102159566A Pyridone and pyridazone analogues as gpr119 modulators |
| 08/17/2011 | CN102159565A Benzimidazole compound in crystal form and salt thereof |
| 08/17/2011 | CN102159563A Novel substituted sulfamide derivatives |
| 08/17/2011 | CN102159557A Piperazine d3 and 5-ht2a receptor modulators |
| 08/17/2011 | CN102159544A Pyridyl modulators of gamma-secretase |
| 08/17/2011 | CN102159543A Novel triazolo(4,3-a)pyridine derivatives, process for preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 08/17/2011 | CN102159284A Pharmaceutical combination of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and antiepileptic |
| 08/17/2011 | CN102159249A Pegylated opioids with low potential for abuse |
| 08/17/2011 | CN102159237A Compositions and methods for treatment during non-acute periods following cns neurological injury |
| 08/17/2011 | CN102159232A Treatment of inflammatory diseases with mammal beta defensins |
| 08/17/2011 | CN102159228A Composition comprising a hot water extract of hemerocallis plants, said composition being effective in treating fatigue by having antidepressant properties or by improving sleep |
| 08/17/2011 | CN102159215A Treating various disorders using trkb agonists |
| 08/17/2011 | CN102159199A Composition containing 4-o-methylhonokiol for treating or preventing amyloid-related diseases |
| 08/17/2011 | CN102154301A Preparation and application of conotoxin striatus S21a in South China Sea |
| 08/17/2011 | CN102154300A Conus lividus neurotoxin and coding sequence and use thereof |
| 08/17/2011 | CN102153614A Method for preparing effective monomer of total alkaloid extract of holarrhena antidysenterica and application thereof |
| 08/17/2011 | CN102153562A Spiro-oxindole compounds and their uses as therapeutic agents |
| 08/17/2011 | CN102153549A Gamma carboline compound as well as preparation method and application thereof |
| 08/17/2011 | CN102153539A 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 08/17/2011 | CN102153538A Benzocyclodirivative |
| 08/17/2011 | CN102153505A Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 08/17/2011 | CN102153498A Resveratrol analogue and preparation method and application thereof |
| 08/17/2011 | CN102153471A Idebenone succinate monoester and preparation method thereof |